Under inclement weather, Wiggins Library will be closed on Saturday, January 31st. The library's second floor study area will remain open and research assistance will be available virtually.

3rd Annual Academic Symposium - Satish Rekulapally

3:30pm - 4:30pm (1st floor Wiggins)
Quantification of Calcium/Calmodulin-dependent Protein Kinase- II Activity by a Non-radioactive Method using LCMS
by Satish Pawar Rekulapally

Developed under the guidance of:

Dr. Thomas Abraham
Pharmaceutical Sciences
Calcium/Calmodulin-dependent protein kinaseII (CaMKII) is a multifunctional protein kinase that phosphorylates and regulates activity of many substrates in various tissues. Traditional CaMKII activity assays rely on incorporation of radioactivity onto a CaMKII-substrate by utilizing a γ-P32 ATP or on anti-phospho-CAMKII antibodies and are limited by cost and time. Also, γ-P32 ATP has a short half life and can pose health risks to the researchers. Hence, there is a need for a non-radioactive CaMKII activity assay that is as reliable, reproducible and robust as western blotting or radioactive CaMKII activity assays. The goal of the project is to develop a reliable non-radioactive method for the quantification of CaMKII activity in vitro. Modifications could be made to the traditional CaMKII activity assay in order to make it non-radioactive. The important modification is the use of non-radioactive ATP instead of a radio-labeled ATP. After spotting the reaction mixture (as in traditional kinase assay) on Whatman P81 paper (a cationic exchanger), the peptide autocamtide-2 could be eluted into a NaCl solution (with basic pH) after washing off all the other contents with phosphoric acid. The eluted peptides could be separated by liquid chromatography (LC) and a shift of 80 Da could be detected by mass spectrometry (MS) if phosphorylation of the peptide has occurred.